Form
SCHEDULE 13G/A
Passive or exempt beneficial ownership filing.
Medine GmbH - 31 Mar 2025 SCHEDULE 13G/A Report for BioNTech SE Ordinary Shares, no par value per share (EUR1.00 nominal amount) (including Ordinary Shares represented by American Depositary Shares) (BNTX)
- Filing manager
- Medine GmbH
- Reporting owner
- Prof. Ugur Sahin, M.D.
- Beneficially owned shares
- 42,178,034 shares
- Class ownership
- 18%
- Large-stake signal
-
Ownership
18%
Beneficial ownership of this reported class.
Shares
42,178,034 shares
Shares beneficially owned as disclosed.
Event date
31 Mar 2025
Date tied to the ownership event or amendment.
Accepted by SEC
13 May 2025
EDGAR acceptance date.
How to read this large-stake filing
- Schedule 13D/G filings focus on beneficial ownership stakes, not a full portfolio.
- Compare this filing with the holder history and issuer page before treating the percentage as a current position.
- Use amendments to understand whether the disclosed stake increased, decreased, or changed reporting status.
- Symbol
- BNTX
- Shares outstanding
- 239,647,920 shares
- Form type
- SCHEDULE 13G/A
- Accepted by SEC
- 13 May 2025, 18:14:13 UTC
- Event date
- 31 Mar 2025
- SEC filing
- View on sec.gov
Ownership signal
2 signals
Subject security
2 source fields
Source evidence
4 source fields
Key filing fact
Medine GmbH disclosed 18% ownership in BioNTech SE Ordinary Shares, no par value per share (EUR1.00 nominal amount) (including Ordinary Shares represented by American Depositary Shares) (BNTX) on 31 Mar 2025.
Key facts
- Medine GmbH filed SCHEDULE 13G/A for BioNTech SE Ordinary Shares, no par value per share (EUR1.00 nominal amount) (including Ordinary Shares represented by American Depositary Shares) (BNTX).
- Disclosed ownership: 18%.
- Date of event: 31 Mar 2025.
Change
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 13 May 2025, 18:14.
Research use
- This page turns one Schedule 13D/G filing into a quick large-stake read before the raw reporting-person rows.
- Use the linked SEC filing as the source of truth for ownership percentages, shares, and reporting-party details.
Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting persons
Disclosed reporting parties (2)
Names, ownership percentages, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.
| Name | Ownership | Shares owned | Sole voting power | Shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Medine GmbH | 17% | 40,127,697 | 0 | 39,111,390 | /s/ Prof. Ugur Sahin, M.D. | Prof. Ugur Sahin, M.D./Authorized Signatory | |
| Prof. Ugur Sahin, M.D. | 18% | 42,178,034 | 2,050,337 | 40,127,697 | /s/ Prof. Ugur Sahin, M.D. | Prof. Ugur Sahin, M.D. |
CIK / CUSIP context first